Blood Glucose Monitors: Global Intelligence Database Platform (2012-2023) Covering Value, Volume Sales, Price, and Price Per-Capita Expenditure - ResearchAndMarkets.com

The "Blood
Glucose Monitor Intelligence Center 2012-2023" report has been
added to ResearchAndMarkets.com's offering.

The Blood Glucose Monitor Intelligence Center 2012-2023 is a
global intelligence database platform, which provides data covering five
regions with in-depth analysis across 25 countries and five-year
forecast, including value, volume sales, price, and price per-capita
expenditure.

The IC enhances your understanding of the blood glucose monitoring
devices market. The market is also assessed considering the economic
factors that impact the BGM devices market, such as Type-1 diabetic
population levels, Type-2 diabetic population levels, and obesity, which
provide you with actionable business insights.

Market Scope

• There are two main types of BGM devices included in this study,
  namely, self-monitoring blood glucose (SMBG) devices and continuous
  glucose monitoring (CGM) devices. The devices are further categorized
  by components, i.e. the SMBG devices are segmented into glucometer
  devices, test strips, and lancets (which are further studied by their
  usage in hospitals and homes individually), and CGM devices are
  segmented into their component sensors and receivers.
• The BGM devices market data is segmented into types and categories,
  and volume and value analytics with growth trends (2012-2023).
• Market indicators - diabetic population, diabetes disease prevalence,
  Diabetes Type-1 population, Diabetes Type-2 population, and per-capita
  expenditure.
• The BGM IC provides an exhaustive coverage (countries covered account
  for more than 80% of the overall spending on diabetes), covering two
  categories, three segments, and sub-segments based on end users. The
  market tracked covers more than 5,000 data points of the industry.

Categories and Segments

Self-monitoring Blood Glucose Devices:

• Glucometer Devices
• Glucometer Consumables
• Test Strips
• Lancets

By End User:

• Hospital Use
• Personal Use

Continuous Glucose Monitoring Devices:

• Receivers
• Sensors

Market Overview

• The global blood glucose monitoring devices market is expected to
  register a CAGR of 11.88% during the forecast period (2018-2023), and
  it was valued at USD 11.4 billion in 2018.
• Blood glucose monitoring devices are used for effective diabetes
  diagnosis and treatment. The rise in diabetic population levels drives
  the market by increasing the use of blood glucose monitoring devices.
• Obesity is also considered as one of the major factors contributing to
  the disease, primarily Type-2 diabetes.
• Additionally, other factors, such as technological innovations and
  advancements, give much convenience in measuring the blood glucose
  levels. One such advancement in monitoring the blood glucose levels is
  established with continuous glucose monitoring devices.
• These devices help in the early detection of hypo and hyperglycemic
  conditions, which tend to drive the market for glucose monitoring.
• The glucometer consumables segment (test strips and lancets) occupies
  the highest share in the BGM devices market.
• Although CGM is an advanced way for the people suffering from diabetes
  to check glucose readings in real-time, SMBG device is the most
  preferred, due to its economic affordability and simplicity in usage,
  when compared to CGM devices. SMBG devices occupy more than 87% of the
  share in the blood glucose monitoring devices market. In further
  segmentation, the disposable consumables, i.e. test strips and
  lancets, occupy the larger market share, when compared to the
  glucometer devices. However, the CAGR for glucometer devices is high.
• Though the CGM devices provide real-time data of blood glucose levels
  for patients, they have low adaptability in the emerging markets.
  However, the adaptability of CGM devices is high in the developed
  markets. The cost factor is a major concern for the low growth of CGM
  devices in the emerging markets.

Reasons to Purchase this Dashboard

• More granular: Covers more categories, segments, and brands at
  country- and global-levels compared to other market intelligence
  providers
• Analyzing the outlook of the market with the recent market data,
  historical data, and market forecast
• Ease of comparability: Our analytics is based on the standardized
  definition across the world, in order to facilitate better
  comparability of market data
• View the market in different ways among categories and geography to
  understand where the actual opportunity lies
• Market segmentation, including quantitative research, incorporating
  the impact of economic and non-economic aspects
• Regional- and country-level data integrating the demand and supply
  forces that are influencing the growth of the market
• Market value (in USD million) and volume (in unit million) data for
  each segment and sub-segment
• Understanding of the market, due to value and volume changes, and
  intra-category competition.
• Dedicated analyst support for research queries and training
• Continuous amendment of the yearly database with significant changes
  that are updated based on scenarios

List of Topics Covered

1. Introduction
1.1 Key Deliverables of the Study
1.2
Market Definition

2. Research Approach and Methodology
2.1
Introduction
2.2 Research Designs
2.3 Study Phases
2.3.1
Internal sources evaluation
2.3.2 Research Process
2.3.3
Modelling & triangulation
2.3.4 Data finalization
2.3.5
Expert Validation

3. Market Segmentation
3.1 By Device
3.1.1
Monitoring Devices
3.2 By Geography
3.2.1 North America
3.2.2
Europe
3.2.3 Latin America
3.2.4 Asia-Pacific
3.2.5
Middle East and Africa

4. Market Indicators
4.1 Type-1 Diabetes
population (2012-2023)
4.2 Type-2 Diabetes population (2012-2023)

5. Company Analysis

Companies Mentioned

• Abbott Diabetes Care
• Acon
• Agamatrix Inc.
• Arkray
• Ascensia Diabetes Care
• Bionime Corporation
• Dexcom
• Johnson & Johnson
• Medisana
• Medtronic
• Roche
• Rossmax
• Trivida

For more information about this report visit https://www.researchandmarkets.com/research/4bqf8f/blood_glucose?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190315005325/en/